- Home
- IOR vs SRZN Comparison
IOR vs SRZN Comparison
Compare IOR & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOR
- SRZN
- Stock Information
- Founded
- IOR 1984
- SRZN 2015
- Country
- IOR United States
- SRZN United States
- Employees
- IOR N/A
- SRZN N/A
- Industry
- IOR Real Estate Investment Trusts
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- IOR Real Estate
- SRZN Health Care
- Exchange
- IOR Nasdaq
- SRZN Nasdaq
- Market Cap
- IOR 72.8M
- SRZN 85.6M
- IPO Year
- IOR N/A
- SRZN N/A
- Fundamental
- Price
- IOR $18.68
- SRZN $11.14
- Analyst Decision
- IOR
- SRZN Strong Buy
- Analyst Count
- IOR 0
- SRZN 2
- Target Price
- IOR N/A
- SRZN $38.50
- AVG Volume (30 Days)
- IOR 311.0
- SRZN 17.2K
- Earning Date
- IOR 08-07-2025
- SRZN 08-08-2025
- Dividend Yield
- IOR N/A
- SRZN N/A
- EPS Growth
- IOR N/A
- SRZN N/A
- EPS
- IOR 1.06
- SRZN N/A
- Revenue
- IOR N/A
- SRZN $12,621,000.00
- Revenue This Year
- IOR N/A
- SRZN N/A
- Revenue Next Year
- IOR N/A
- SRZN N/A
- P/E Ratio
- IOR $17.69
- SRZN N/A
- Revenue Growth
- IOR N/A
- SRZN N/A
- 52 Week Low
- IOR $16.01
- SRZN $5.90
- 52 Week High
- IOR $19.69
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- IOR 51.14
- SRZN 63.57
- Support Level
- IOR $18.02
- SRZN $9.03
- Resistance Level
- IOR $18.89
- SRZN $11.73
- Average True Range (ATR)
- IOR 0.18
- SRZN 1.05
- MACD
- IOR -0.01
- SRZN 0.10
- Stochastic Oscillator
- IOR 79.38
- SRZN 80.53
About IOR Income Opportunity Realty Investors Inc.
Income Opportunity Realty Investors Inc is a U.S.-based company that is an externally managed company that invests in mortgage notes receivables and real property. The business of the company is managed by Pillar Income Asset Management, Inc. The company's activities include locating, evaluating and recommending investment opportunities. Pillar also arranges its debt and equity financing with unaffiliated independent third party lenders and investors.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).